YABLONKA URI (EVP and Chief Business Officer) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/3/2025ACC: 0001104659-25-000892
DirectorOfficer· EVP and Chief Business Officer
Since Nov 2018
+60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+40K
Price / share
—
Trade value
—
% of position
472.6%
1/1/2025
8.46K→48.46K
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
41.3%
1/1/2025
48.46K→68.46K
Total
Net shares
+60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2025 | A · Award | +40K | — | — | 472.6% | 8.46K | 48.46K |
| Common Stock Direct | 1/1/2025 | A · Award | +20K | — | — | 41.3% | 48.46K | 68.46K |
| Total | +60K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported